Indicators of Inflammation and Coagulation in Sepsis

University of Oklahoma500 enrolled

Overview

We will collect blood samples from patients with the diagnosis of sepsis and other ICU patients. We will describe the course of different mediator levels and organ injury markers and follow their progression throughout the course of the study.

After informed consent is obtained 5 cc of blood is collected on the day of admission and on days 0, 1, 3, and 7 thereafter. Plasma is collected and frozen for the subsequent measurement of biomarkers.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Sepsis

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Admission to the ICU Exclusion Criteria: * No blood draws scheduled * Hemoglobin level \< 6,5 gm/dl

Locations (1)

OU Medical Center

Oklahoma City, Oklahoma, United States

Outcomes

Primary Outcomes

Death

Survival at 30 days

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.